Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)

Yoshihisa Nakagawa(Shiga University of Medical Science), Kazuaki Mitsudo(Kurashiki Central Hospital), Hideo Nishikawa, Yasuhiko Hayashi(Kindai University Hospital), Yoshikazu Hiasa(Tokushima Red Cross Hospital), Tomohiro Kawasaki(Koga Hospital), Toshiya Muramatsu(Mitsubishi UFJ Research & Consulting (Japan)), Kazushige Kadota(Kurashiki Central Hospital), Nobuo Shiode(Hiroshima General Hospital), Takeshi Morimoto(Hyogo Medical University), Takeshi Kimura(Municipal Hirakata City Hospital), Masanori Nomura(Fujita Health University), Shunichi Miyazaki, Hiroshi Fujita(Massachusetts General Hospital), Yoshisato Shibata, Yoshiharu Murata(Nagoya Memorial Hospital), Masunori Matsuzaki(Ube (Japan)), Masakiyo Nobuyoshi(Kurume University), Keijiro Saku(Fukuoka University Hospital), Seiichi Haruta, Ryozo Tatami(Kanazawa University), Osamu Doi(Shizuoka General Hospital), Takashi Honda(Osaka Hospital)
The American Journal of Cardiology
June 20, 2010
10.1016/j.amjcard.2010.03.031
Cited by 95

Related Papers

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion
|Circulation|2019|398